VitaSignal: AI-Powered Clinical Decision Support
Tagline: Clinical Intelligence Without Equipment — predicting ICU patient deterioration from documentation patterns, not devices.
Inspiration
As an informaticist and clinical researcher, I witnessed firsthand how patient deterioration often goes undetected — not because clinicians aren't attentive, but because the signals are buried in documentation patterns that humans can't process in real time.
The Intensive Documentation Index (IDI) was born from a simple insight: how clinicians document reveals as much about patient status as what they document.
What It Does
VitaSignal™ LLC is a Gemini 3-powered clinical decision support platform that predicts ICU patient deterioration using 9 temporal patterns in existing EHR documentation — without requiring physiological sensors, lab values, or additional medical devices.
Two core systems:
- IDI (Intensive Documentation Index) — predicts ICU mortality risk from documentation timing patterns, validated across independent international cohorts in the USA and Switzerland
- DBS (Documentation Burden Score) — predicts nursing workload and burnout risk, validated across U.S. hospitals
Gemini 3-powered features:
- Clinical Notes Analyzer — extracts early warning signs from free-text nurse observations in real time
- Explainable Risk Narratives — converts SHAP outputs into plain-language bedside explanations
- Intervention Recommender — surfaces evidence-based nursing interventions by clinical urgency
- Health Equity Analyzer — detects demographic disparities in AI risk predictions (NIH AIM-AHEAD aligned)
⚠️ Decision-support only. All findings require clinical verification. Not a medical device.
How We Built It
- Frontend: React + TypeScript + Tailwind CSS, deployed on cloud-hosted production infrastructure
- AI Engine: Dual Gemini 3 model integration — Flash for speed-critical analysis, Pro for complex reasoning
- Backend: Supabase (PostgreSQL, Edge Functions, Row-Level Security)
- Security: No API keys in client code — all AI routed through secure server-side gateway; HIPAA-safe synthetic data only
- Research Foundation: Validated across independent international ICU cohorts, with manuscripts under review
- Patent Portfolio: 11 U.S. Provisional Patent Applications Filed — February 28, 2026
Challenges We Faced
- Balancing clinical accuracy with real-time performance — solved using Gemini 3 Flash for triage and Pro for deep analysis
- Making complex ML predictions interpretable for bedside clinicians without statistical backgrounds
- Ensuring health equity by detecting and surfacing potential demographic bias in risk predictions
- Demonstrating that documentation timing alone — with no physiological data — could outperform established clinical severity scores validated over decades
What We Learned
Gemini 3's multimodal reasoning capabilities are transformative for healthcare AI. The ability to analyze clinical narratives, generate human-readable explanations, and reason about intervention timing in a single model family dramatically simplifies the clinical AI pipeline.
The strongest signal in clinical AI may not come from what is documented — but from the rhythm and timing of documentation itself, a finding now validated across independent international databases spanning two countries.
What's Next
- Accepted: ANIA 2026, Boston, MA — March 26–28, 2026
- IRB-approved prospective clinical validation — pilot site recruitment underway (Q2 2026)
- Real-time EHR integration via FHIR APIs
- FDA pre-submission meeting (2026)
- Expansion to sepsis early warning, shift handoff quality scoring, and global health settings
Built With
react typescript tailwind-css supabase edge-functions postgresql gemini-3-flash gemini-3-pro recharts framer-motion vite
Try It Out
© 2026 VitaSignal LLC. All rights reserved. Patent Pending — USPTO. Submitted to Gemini 3 Hackathon 2026 | Powered by Google Gemini 3 API
Built With
- edge-functions
- framer-motion
- gemini-3-flash
- gemini-3-pro
- postgresql
- react
- recharts
- supabase
- tailwind-css
- typescript
- vite
Log in or sign up for Devpost to join the conversation.